In vitro cytostatic activity on new ruthenium complexes with heterocyclic dithiocarbamates.
Papaioannou
A
A
Institute of Pharmacology and Pharmacognosy, Trieste.
Scarcia
V
V
Furlani
A
A
Preti
C
C
D002470:Cell Survival / Q000187:drug effects*; D006571:Heterocyclic Compounds / Q000633:toxicity*; D006801:Humans; D007624:KB Cells / Q000187:drug effects; D010084:Oxidation-Reduction; D012428:Ruthenium / Q000633:toxicity*; D013859:Thiocarbamates / Q000633:toxicity*
D006571:Heterocyclic Compounds; D013859:Thiocarbamates; D012428:Ruthenium